Tagged with US

Amcham The American Chamber of Commerce’s executive director in Thailand explains the chamber’s role in facilitating mutually beneficial relations between American businesses and Thailand, the challenges and opportunities that exist for foreign investment and the code of ethics the US seeks to promote within the local Thai economy. Where does the…

Chiesi Turkey is quickly becoming a regional hub for pharmaceutical industry for management, clinical trials and manufacturing, explains the general manager of Chiesi Turkey. How important is it for the government to clarify the incentives that have been discussed? The healthcare system in Turkey has undergone the largest transition in its…

association The executive director of the German Chamber of Commerce in Romania explains why German companies are deeply embedded in the Romanian market, why the country should be seriously considered as an investment opportunity into Southeast Europe and how the local healthcare system is in need of extra funding, with public…

law firm One of the original market builders of the commercial law practice in Romania analyses the state of in-country legal firms in catering to the evolving needs of pharmaceutical industry players in a rapidly and radically transforming regulatory landscape. An expert in privatisation, he also explains why attempts to inject market…

association PReMA’s CEO discusses the association’s role within the industry as an organization that is improving the healthcare system in Thailand and on helping companies in the pharmaceutical industry bring innovation and high quality productsn to Thailand. You were recently appointed as the CEO of PReMA. What have been your biggest challenges…

Servier Turkey is a key market in the region for Servier, says general manager Philippe Méa, largely due to the country’s relatively strong and stable vision for the healthcare industry. The success of single pill combinations will be a milestone for Servier’s business model.  You arrived in Turkey eight months ago,…

biotech Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow further when they finish development of their second generation botulinum toxin product that will be commercialized globally (outside of Japan and Korea) by Botox manufacturer Allergan. What…

CRM Starting a new business is no easy task. The general manager of Alliance SFA shares his experience, how he decided to focus on second-tier and niche players to offer tailor-made CRM solutions to optimize sales force performance and innovative channels to approach an increasingly informed patient. What was the vision…

consulting IMS’s top consultant in Turkey discusses the common pattern that companies in Turkey have and must follow to adapt to today’s market, and the importance of heeding market signals, such as the growing specialty drugs segment and shift towards the hospital sales channel. What changes have you seen in the…

Otsuka The managing director of Otsuka’s 50-50 joint venture with Turkish giant Abdi Ibrahim, Abdi Ibrahim Otsuka, discusses the mutual advantage the companies can offer each other, and branding Abdi Ibrahim Otsuka as an innovative player on the Turkish arena. What were the initial aspirations in establishing the joint venture between…

World Medicine The founder and chairman of the rapidly expanding World Medicine group of companies discusses his firm’s international expansion strategy, how he came to the decision to invest in production and R&D facilities in Turkey, and the strong support World Medicine has from the Turkish government. How did you originally come…

Menarini Menarini’s Turkish subsidiary, Ibrahim Etem Menarini, has adapted to the current pharmaceutical market and is positioned to grow in several segments including their new OTC business, but is constrained by their current capacity which has minimal excess in some specific lines of production. Uğur Bingöl, the new managing director discusses…